Cargando…

Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes

BACKGROUND: Torsade de pointes (TdP) is a potentially fatal cardiac arrhythmia that is often drug induced. Clinical decision support (CDS) may help minimize TdP risk by guiding decision making in patients at risk. CDS has been shown to decrease prescribing of high‐risk medications in patients at ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Tyler, Heise, C. William, Woosley, Raymond L., Tisdale, James E., Tan, Malinda S., Gephart, Sheila M., Antonescu, Corneliu C., Malone, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238706/
https://www.ncbi.nlm.nih.gov/pubmed/35656987
http://dx.doi.org/10.1161/JAHA.122.024338
_version_ 1784737121537359872
author Gallo, Tyler
Heise, C. William
Woosley, Raymond L.
Tisdale, James E.
Tan, Malinda S.
Gephart, Sheila M.
Antonescu, Corneliu C.
Malone, Daniel C.
author_facet Gallo, Tyler
Heise, C. William
Woosley, Raymond L.
Tisdale, James E.
Tan, Malinda S.
Gephart, Sheila M.
Antonescu, Corneliu C.
Malone, Daniel C.
author_sort Gallo, Tyler
collection PubMed
description BACKGROUND: Torsade de pointes (TdP) is a potentially fatal cardiac arrhythmia that is often drug induced. Clinical decision support (CDS) may help minimize TdP risk by guiding decision making in patients at risk. CDS has been shown to decrease prescribing of high‐risk medications in patients at risk of TdP, but alerts are often ignored. Other risk‐management options can potentially be incorporated in TdP risk CDS. Our goal was to evaluate actions clinicians take in response to a CDS advisory that uses a modified Tisdale QT risk score and presents management options that are easily selected (eg, single click). METHODS AND RESULTS: We implemented an inpatient TdP risk advisory systemwide across a large health care system comprising 30 hospitals. This CDS was programmed to appear when prescribers attempted ordering medications with a known risk of TdP in a patient with a QT risk score ≥12. The CDS displayed patient‐specific information and offered relevant management options including canceling offending medications and ordering electrolyte replacement protocols or ECGs. We retrospectively studied the actions clinicians took within the advisory and separated by drug class. During an 8‐month period, 7794 TdP risk advisories were issued. Antibiotics were the most frequent trigger of the advisory (n=2578, 33.1%). At least 1 action was taken within the advisory window for 2700 (34.6%) of the advisories. The most frequent action taken was ordering an ECG (n=1584, 20.3%). Incoming medication orders were canceled in 793 (10.2%) of the advisories. The frequency of each action taken varied by drug class (P<0.05 for all actions). CONCLUSIONS: A modified Tisdale QT risk score–based CDS that offered relevant single‐click management options yielded a high action/response rate. Actions taken by clinicians varied depending on the class of the medication that evoked the TdP risk advisory, but the most frequent was ordering an ECG.
format Online
Article
Text
id pubmed-9238706
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92387062022-06-30 Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes Gallo, Tyler Heise, C. William Woosley, Raymond L. Tisdale, James E. Tan, Malinda S. Gephart, Sheila M. Antonescu, Corneliu C. Malone, Daniel C. J Am Heart Assoc Original Research BACKGROUND: Torsade de pointes (TdP) is a potentially fatal cardiac arrhythmia that is often drug induced. Clinical decision support (CDS) may help minimize TdP risk by guiding decision making in patients at risk. CDS has been shown to decrease prescribing of high‐risk medications in patients at risk of TdP, but alerts are often ignored. Other risk‐management options can potentially be incorporated in TdP risk CDS. Our goal was to evaluate actions clinicians take in response to a CDS advisory that uses a modified Tisdale QT risk score and presents management options that are easily selected (eg, single click). METHODS AND RESULTS: We implemented an inpatient TdP risk advisory systemwide across a large health care system comprising 30 hospitals. This CDS was programmed to appear when prescribers attempted ordering medications with a known risk of TdP in a patient with a QT risk score ≥12. The CDS displayed patient‐specific information and offered relevant management options including canceling offending medications and ordering electrolyte replacement protocols or ECGs. We retrospectively studied the actions clinicians took within the advisory and separated by drug class. During an 8‐month period, 7794 TdP risk advisories were issued. Antibiotics were the most frequent trigger of the advisory (n=2578, 33.1%). At least 1 action was taken within the advisory window for 2700 (34.6%) of the advisories. The most frequent action taken was ordering an ECG (n=1584, 20.3%). Incoming medication orders were canceled in 793 (10.2%) of the advisories. The frequency of each action taken varied by drug class (P<0.05 for all actions). CONCLUSIONS: A modified Tisdale QT risk score–based CDS that offered relevant single‐click management options yielded a high action/response rate. Actions taken by clinicians varied depending on the class of the medication that evoked the TdP risk advisory, but the most frequent was ordering an ECG. John Wiley and Sons Inc. 2022-06-03 /pmc/articles/PMC9238706/ /pubmed/35656987 http://dx.doi.org/10.1161/JAHA.122.024338 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Gallo, Tyler
Heise, C. William
Woosley, Raymond L.
Tisdale, James E.
Tan, Malinda S.
Gephart, Sheila M.
Antonescu, Corneliu C.
Malone, Daniel C.
Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes
title Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes
title_full Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes
title_fullStr Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes
title_full_unstemmed Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes
title_short Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes
title_sort clinician responses to a clinical decision support advisory for high risk of torsades de pointes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238706/
https://www.ncbi.nlm.nih.gov/pubmed/35656987
http://dx.doi.org/10.1161/JAHA.122.024338
work_keys_str_mv AT gallotyler clinicianresponsestoaclinicaldecisionsupportadvisoryforhighriskoftorsadesdepointes
AT heisecwilliam clinicianresponsestoaclinicaldecisionsupportadvisoryforhighriskoftorsadesdepointes
AT woosleyraymondl clinicianresponsestoaclinicaldecisionsupportadvisoryforhighriskoftorsadesdepointes
AT tisdalejamese clinicianresponsestoaclinicaldecisionsupportadvisoryforhighriskoftorsadesdepointes
AT tanmalindas clinicianresponsestoaclinicaldecisionsupportadvisoryforhighriskoftorsadesdepointes
AT gephartsheilam clinicianresponsestoaclinicaldecisionsupportadvisoryforhighriskoftorsadesdepointes
AT antonescucorneliuc clinicianresponsestoaclinicaldecisionsupportadvisoryforhighriskoftorsadesdepointes
AT malonedanielc clinicianresponsestoaclinicaldecisionsupportadvisoryforhighriskoftorsadesdepointes